Gilead's remdesivir reduces coronavirus mortality risk: Study


Gilead's remdesivir reduces coronavirus mortality risk: Study



Family emergency medicine physician Dr. Janette Nesheiwat applauds President Trump for securing 100 percent of remdesivir for the month of July and 90 percent for August and September since there's now a shortage of the drug.

Gilead's remdesivir reduces coronavirus mortality risk: Study Gilead's remdesivir reduces coronavirus mortality risk: Study Reviewed by SUJAL PANDHARE on July 10, 2020 Rating: 5

No comments:

Powered by Blogger.